We are live on
!
Find out more
HP
Harbourvest Partners Portfolio holdings
AUM
$101M
1-Year Est. Return
38.13%
This Fund
S&P 500
This Quarter
Est. Return
+17.19%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$256M
AUM Growth
-$14.3M
(-5.3%)
Cap. Flow
-$6.57M
Cap. Flow
% of AUM
-2.57%
Top 10 Holdings %
Top 10 Hldgs %
95.13%
Holding
40
New
5
Increased
–
Reduced
3
Closed
14
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
|
+$25.9M |
| 2 |
Seres Therapeutics
MCRB
|
+$2.46M |
| 3 |
WORK
Slack Technologies, Inc.
WORK
|
+$2.06M |
| 4 |
ADVM
Adverum Biotechnologies
ADVM
|
+$1.66M |
| 5 |
RAPT
RAPT Therapeutics
RAPT
|
+$336K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ONEM
1Life Healthcare
ONEM
|
+$9.97M |
| 2 |
SWI
SolarWinds Corporation Common Stock
SWI
|
+$9M |
| 3 |
PS
Pluralsight, Inc. Class A Common Stock
PS
|
+$3.03M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$2.5M |
| 5 |
Nutanix
NTNX
|
+$2.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.29% |
| 2 | Technology | 46.24% |
| 3 | Financials | 2.12% |
| 4 | Consumer Discretionary | 1.04% |
| 5 | Energy | 0.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Hallador Energy
HNRG
$646M
| $21K | 0.01% |
14,270
| – | – |
|
27
Arvinas
ARVN
$530M
| – | – |
-16,666
| Closed | -$393K |
|
28
Black Diamond Therapeutics
BDTX
$95.1M
| – | – |
-9,581
| Closed | -$290K |
|
29
Lyft
LYFT
$5.86B
| – | – |
-25,785
| Closed | -$710K |
|
|
30
Nutanix
NTNX
$16.1B
| – | – |
-106,049
| Closed | -$2.35M |
|
31
PagerDuty
PD
$830M
| – | – |
-67,891
| Closed | -$1.84M |
|
32
Phreesia
PHR
$689M
| – | – |
-24,562
| Closed | -$789K |
|
33
The RealReal
REAL
$1.41B
| – | – |
-7,300
| Closed | -$106K |
|
|
SFIX
34
Stitch Fix
SFIX
$567M
| – | – |
-66,571
| Closed | -$1.81M |
|
35
Veracyte
VCYT
$4.45B
| – | – |
-23,591
| Closed | -$766K |
|
|
ISEE
36
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-442,810
| Closed | -$2.5M |
|
|
ONEM
37
DELISTED
1Life Healthcare
ONEM
| – | – |
-351,480
| Closed | -$9.97M |
|
|
CNST
38
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| – | – |
-49,614
| Closed | -$1M |
|
|
PS
39
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| – | – |
-176,807
| Closed | -$3.03M |
|
Similar funds
VCM
TCI
RPC
XC
AWA
HWM
CG
ROP
Harbourvest Partners's Q4 2020 Portfolio in Review
As of Q4 2020, Harbourvest Partners held 40 positions worth $256M, down 5.3% from $270M the previous quarter. Its ten largest holdings account for 95% of the portfolio.
Harbourvest Partners's Q4 2020 filing shows 5 new, 3 reduced and 14 closed positions. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 56,980 shares worth $35.6M. The largest sale was 1Life Healthcare, an estimated $9.97M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 33% a quarter earlier, followed by Technology and Financials.
- Harbourvest Partners's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 56,980 shares worth $35.6M.
- Harbourvest Partners's biggest Q4 2020 reduction was SolarWinds Corporation Common Stock, cutting an estimated $9M.
- Harbourvest Partners fully exited 1Life Healthcare in Q4 2020, selling an estimated $9.97M.
- Harbourvest Partners's ten largest holdings make up 95% of its $256M portfolio in Q4 2020.
- Harbourvest Partners opened 5 new positions and closed 14 in Q4 2020.
- Harbourvest Partners's portfolio value fell 5.3% quarter-over-quarter to $256M.
Based on Harbourvest Partners's 13F filing for Q4 2020, filed 16 Feb 2021.